| Melanie Suzanne Brown, PA | |
|
3400 Lebanon Rd, Murfreesboro, TN 37129-1237 | |
| (615) 867-6000 | |
| Not Available |
| Full Name | Melanie Suzanne Brown |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 3400 Lebanon Rd, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184737140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Suzanne Brown, PA 1711 Bear Paw Ln, Murfreesboro, TN 37130-1455 Ph: (615) 867-6000 | Melanie Suzanne Brown, PA 3400 Lebanon Rd, Murfreesboro, TN 37129-1237 Ph: (615) 867-6000 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
TikoMed AB, a biotechnology company focused on the development and commercialization of innovative treatments of immune diseases and transplantation therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted TM-400 Orphan Drug Designation for the mobilization of stem cells prior to stem cell transplantation treatment.
DBV Technologies announced today that it has received "Fast Track Designation" for the Clinical Development Program of its Viaskin Peanut, a product designed for the treatment by Epicutaneous Immunotherapy (EPIT) of patients with peanut allergy.
› Verified 5 days ago
Benjamin James Stasik, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Mr. Caleb David Miner, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 400 North Highland Ave, Middle Tennessee Medical Center, Murfreesboro, TN 37130 Phone: 904-953-2000 | |
Emma Grace Aiken, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1574 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-225-2070 | |
Mr. Jason Henry Huddleston, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-695-1483 | |
Mr. Michael Dawson Maddox, PA C Physician Assistant Medicare: Medicare Enrolled Practice Location: 951 New Salem Hwy, Murfreesboro, TN 37129 Phone: 615-907-0123 Fax: 615-907-0133 | |
Joe A Shaw, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Dr, Murfreesboro, TN 37129 Phone: 161-589-3448 | |
Lana Danielle Spry, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1574 Medical Center Pkwy Ste 104, Murfreesboro, TN 37129 Phone: 615-225-2070 |